Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maribel Guerra-Vallespi"'
Autor:
Maribel Guerra-Vallespi, Julio R Fernández-Massó, Osvaldo Reyes-Acosta, Hilda Garay-Pérez, Isis Torrens-Madrazo, Milaid Granadillo-Rodríguez, Brizaida Oliva-Argüelles, Isbel García, Isabel Guillén-Pérez, Daniel Palenzuela-Gardón, Dania Vázquez-Blomquist, Viviana Falcón-Cama, Osmany Mendoza-Fuentes, Orlando Borras-Hidalgo, Lidia I Novoa-Pérez, Mariela Vázquez-Castillo
Publikováno v:
Biotecnología Aplicada, Vol 31, Iss 4, Pp 328-331
In previous work, we identified the peptide comprising amino acids 32-51 on the antimicrobial protein limulus anti-LPS factor (LALF) from Limulus poliphemus, based on its capacity to bind to the bacterial lipopolysaccharide (LPS). In this study, we d
Externí odkaz:
https://doaj.org/article/c9c9eb16bc304ab88aed0f4885b54865
Synthetic therapeutic peptides (STP) are intensively studied as new-generation drugs, characterized by high purity, biocompatibility, selectivity and stereochemical control. However, most of the studies are focussed on the bioactivity of STP without
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2659::938fc2825b9fbfed4cb72aa3b78e84eb
https://zenodo.org/record/6395810
https://zenodo.org/record/6395810
Autor:
Yolanda Gomez Rodriguez, Brizaida Oliva Arguelles, Mario Riera Romo, Jorge Fernandez-De-Cossio, Hilda Elisa Garay Perez, Julio Raul Fernandez Masso, Maribel Guerra Vallespi
Non-small cell lung cancer constitutes one the most frequent and lethal forms of the disease. The antitumor peptide CIGB-552 is a new targeted anticancer therapy which molecular mechanism is associated with the inhibition of the transcription factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29487235fa68d7a51b88a88ef6f0726e
https://doi.org/10.21203/rs.3.rs-620068/v1
https://doi.org/10.21203/rs.3.rs-620068/v1
Autor:
Teresa Núñez de Villavicencio-Díaz, Yassel Ramos Gómez, Brizaida Oliva Argüelles, Julio R. Fernández Masso, Arielis Rodríguez-Ulloa, Yiliam Cruz García, Osmany Guirola-Cruz, Yasset Perez-Riverol, Luis Javier González, Inés Tiscornia, Sabina Victoria, Mariela Bollati-Fogolín, Vladimir Besada Pérez, Maribel Guerra Vallespi
Publikováno v:
Data in Brief
Data in Brief, Vol 4, Iss C, Pp 468-473 (2015)
Data in Brief, Vol 4, Iss C, Pp 468-473 (2015)
CIGB-552 is a second generation antitumor peptide that displays potent cytotoxicity in lung and colon cancer cells. The nuclear subproteome of HT-29 colon adenocarcinoma cells treated with CIGB-552 peptide was identified and analyzed [1]. This data a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44a14a6575ad1a32c1871b7f4467a498
https://pubmed.ncbi.nlm.nih.gov/26306321
https://pubmed.ncbi.nlm.nih.gov/26306321
Autor:
Francesca Cavalieri, Ernesto Placidi, Emanuela Gatto, Rita Cimino, Gianfranco Bocchinfuso, Julio Raul Fernandez Masso, Lorenzo Antonelli, Héctor Santana, Mariano Venanzi, Hilda Elisa Garay Perez, Maribel Guerra-Vallespi, Marco Savioli
Publikováno v:
Journal of Peptide Science. 28(1)
Synthetic therapeutic peptides (STP) are intensively studied as new-generation drugs, characterized by high purity, biocompatibility, selectivity and stereochemical control. However, most of the studies are focussed on the bioactivity of STP without
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72175da65b589a7a64e98b2bbd32dd61